A valid controlled substance prescription in Tennessee has to clear several layers at once: the prescriber must be licensed and DEA-registered, the prescription itself must carry specific information in the right format, the prescriber must check the state monitoring database for opioids and benzodiazepines, and the pharmacy has to label and record the dispensing correctly. The Tennessee controlled substance prescription requirements sit on top of federal DEA rules, and a mistake at any step can bring license discipline, criminal charges, or both.
Who Can Prescribe
Only practitioners who hold a Tennessee license with prescriptive authority and a current DEA registration may prescribe Schedule II through V drugs. That group includes physicians (MD and DO), dentists, podiatrists, and optometrists with therapeutic certification. Advanced practice registered nurses and physician assistants can prescribe controlled substances too, but only under added conditions.
A physician assistant needs a written supervisory protocol with a physician that specifically authorizes controlled substance prescribing.1Justia. Tennessee Code 63-19-107 – Prescribing and Dispensing Drugs An APRN needs a collaborative agreement with a supervising physician that lists the drugs the APRN can prescribe, and that agreement has to be registered with the licensing board.2Justia. Tennessee Code 63-7-123 – Collaborative Pharmacy Practice Agreements
What the Prescription Must Contain
Every controlled substance prescription must include the prescriber’s full name, address, and DEA number, along with the patient’s full name and address.3Justia. Tennessee Code 53-10-205 – Prescription Requirements It also has to identify the drug name, strength, dosage form, quantity, and directions for use.
Schedule II prescriptions must be written or transmitted electronically. Verbal orders are permitted only in genuine emergencies.4Justia. Tennessee Code 53-11-308 – Prescription Requirements Electronic prescriptions have to meet DEA security standards, including two-factor authentication. Prescribers who participate in Medicare Part D must transmit at least 70 percent of their controlled substance prescriptions electronically. There are narrow exceptions for low-volume prescribers with 100 or fewer such prescriptions a year, practitioners in declared disaster areas, and those granted a CMS waiver.5eCFR. 42 CFR 423.160 – Standards for Electronic Prescribing
The pharmacist has an independent duty here. Before filling a controlled substance prescription, the pharmacist has to evaluate whether it was issued for a legitimate medical purpose. Unusual quantities, drug combinations associated with misuse, or a prescriber located far from the patient’s home are the kinds of signals a pharmacist is expected to investigate, resolve, and document before dispensing.
Checking the CSMD Before You Prescribe
Tennessee’s Controlled Substance Monitoring Database tracks every controlled substance dispensed in the state. Before writing an opioid or benzodiazepine, the prescriber must check the CSMD to review the patient’s prescription history.6Justia. Tennessee Code 53-10-310 – Controlled Substance Database Checks The commissioner can extend that requirement to other Schedule II through V substances that show abuse potential.
There are limited exceptions for hospice patients and for small-quantity prescriptions. Outside those situations, skipping the check is a compliance violation.
Dispensers report to the CSMD on their side. Pharmacies must submit each controlled substance dispensing no later than the close of business on the following business day. Veterinarians get 14 days.7TN.gov. Tennessee CSMD Data Collection Manual
Refill Rules by Schedule
What the prescriber can put on the prescription depends on the drug’s schedule:
- Schedule II drugs (oxycodone, fentanyl, amphetamines): no refills, ever. A patient who needs continued treatment needs a new prescription each time.4Justia. Tennessee Code 53-11-308 – Prescription Requirements
- Schedule III and IV drugs (ketamine, certain codeine combinations, benzodiazepines, sedatives): up to five refills within six months of the date written. After that window, a new prescription is required.
- Schedule V drugs (low-dose codeine cough preparations, gabapentin in Tennessee, some anti-diarrheals): dispensed only for a medical purpose, with no specific statutory refill cap. Pharmacists document each dispensing.8Justia. Tennessee Code 39-17-414 – Schedule V
Partial Fills of Schedule II
If the pharmacy doesn’t have the full quantity of a Schedule II drug on hand, federal rules allow a partial fill. The remainder must be dispensed within 72 hours; otherwise, the prescriber has to be notified and a new prescription is needed. When the prescriber or patient asks for a partial fill voluntarily, the balance must be dispensed within 30 days of the date written.9eCFR. 21 CFR 1306.13 – Partial Filling of Prescriptions For patients in long-term care facilities or with a documented terminal illness, the prescription remains valid for up to 60 days.
Tennessee expects the pharmacist to report only the partial quantity actually dispensed to the CSMD, not the full prescribed amount, and to note both the quantity dispensed and the reason for the partial fill in the prescription record.
Opioid Supply Limits and the Naloxone Offer
Tennessee applies tighter rules to opioids than to other controlled substances. For acute pain, the default limit is a three-day supply at a dosage not exceeding 180 morphine milligram equivalents.10Justia. Tennessee Code 63-1-164 – Restrictions and Limitations on Treating Patient With Opioids
A prescriber can exceed the three-day limit, but only after personally evaluating the patient, documenting why non-opioid alternatives failed or weren’t attempted, including the ICD-10 code for the primary condition on the prescription, and obtaining informed consent. Only one opioid prescription per patient encounter is permitted. For a procedure that is more than minimally invasive, where pain risks outweigh addiction risks, a prescriber may write up to a 30-day supply capped at 1,200 morphine milligram equivalents.
Whenever a prescriber writes more than a three-day opioid supply, prescribes an opioid alongside a benzodiazepine, or prescribes for a patient at elevated overdose risk (a history of overdose, a substance use disorder diagnosis, or a return to a high opioid dose after reduced tolerance), the prescriber must offer the patient a naloxone prescription. Palliative care patients are exempt.4Justia. Tennessee Code 53-11-308 – Prescription Requirements
Prescribing by Telehealth
Federal law under the Ryan Haight Act generally requires an in-person evaluation before a provider prescribes a controlled substance by telehealth. The DEA has extended pandemic-era flexibility through December 31, 2026, letting DEA-registered practitioners prescribe Schedule II through V drugs by audio-video telehealth without a prior in-person visit, provided the prescription is for a legitimate medical purpose and follows all other DEA rules.11United States Drug Enforcement Administration. DEA Extends Telemedicine Flexibilities to Ensure Continued Access to Care For Schedule III through V medications used to treat opioid use disorder, audio-only encounters are enough.12Federal Register. Fourth Temporary Extension of COVID-19 Telemedicine Flexibilities for Prescription of Controlled Medications
Tennessee adds its own limits. A physician who holds only a Tennessee telemedicine license, rather than a full unrestricted medical license, cannot prescribe controlled substances at all. A physician with a full license may prescribe by telehealth, but must complete the same history, exam, diagnosis, and treatment-plan steps required for an in-person visit. Tennessee’s Chronic Pain Guidelines separately prohibit treating chronic pain through telemedicine, and pain management clinic services follow their own standards.13TN.gov. Tennessee Board of Medical Examiners FAQ: Telemedicine
Labeling and Recordkeeping at the Pharmacy
Every dispensed controlled substance must carry a label showing the patient’s full name, the prescriber’s name, the pharmacy’s name and address, and the drug name, strength, quantity dispensed, and directions for use.14Justia. Tennessee Code 53-11-309 – Labeling Requirements Federal law also requires a transfer warning that giving the medication to anyone other than the patient is prohibited, and opioid labels must carry additional warnings about addiction and overdose. The Tennessee Board of Pharmacy can discipline pharmacies that fail these requirements.
Prescribers and pharmacists must retain controlled substance prescription records for at least two years and produce them for inspection by the Tennessee Department of Health, the DEA, and other regulators.4Justia. Tennessee Code 53-11-308 – Prescription Requirements Paper records must be stored securely; electronic records must meet DEA e-prescribing standards, including encryption and access controls.
Penalties for Getting It Wrong
Tennessee treats controlled substance prescription fraud as a Class D felony, with two to 12 years in prison and a fine of up to $5,000.15Justia. Tennessee Code 53-11-402 – Fraud – Penalties16Justia. Tennessee Code 40-35-111 – Authorized Terms of Imprisonment and Fines for Felonies and Misdemeanors Smaller-quantity violations may be charged as a Class A misdemeanor, while fraud involving more than 250 units of a controlled substance rises to a Class E felony. Intentional distribution outside a legitimate medical purpose can also draw federal charges under the Controlled Substances Act.
Administrative consequences often bite harder than criminal ones for providers. The Tennessee Board of Medical Examiners, the Board of Nursing, and the Board of Pharmacy can each suspend, revoke, or restrict a practitioner’s license. The DEA can revoke a registration when it finds an imminent danger to public health or safety, defined as a substantial likelihood that death, serious bodily harm, or drug abuse will occur without immediate suspension.17Drug Enforcement Administration. Administrative Actions Losing a DEA number ends the ability to prescribe or dispense any controlled substance, which for many specialties is the end of clinical practice. Improper prescribing can also lead to civil liability, particularly where reckless prescribing contributes to an overdose or death.